Cargando…
Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance
In the era of increasing macrolide- and quinolone-resistant Mycoplasma genitalium (MG), we report the efficacy of 2 nonquinolone antimicrobials in patients with limited treatment options. Pristinamycin + doxycycline cured 75% (95% CI, 64%–85%), and minocycline cured 71% (95% CI, 54%–85%) of cases. T...
Autores principales: | Doyle, Michelle, Vodstrcil, Lenka A, Plummer, Erica L, Aguirre, Ivette, Fairley, Christopher K, Bradshaw, Catriona S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408185/ https://www.ncbi.nlm.nih.gov/pubmed/32782911 http://dx.doi.org/10.1093/ofid/ofaa291 |
Ejemplares similares
-
Efficacy of Minocycline for the Treatment of Mycoplasma genitalium
por: Clarke, Emily J, et al.
Publicado: (2023) -
Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium
por: Durukan, Duygu, et al.
Publicado: (2020) -
Persistence of Mycoplasma genitalium Following Azithromycin Therapy
por: Bradshaw, Catriona S., et al.
Publicado: (2008) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men
por: Chua, Teck-Phui, et al.
Publicado: (2021)